What are the management strategies for hypernatremia and hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyponatremia and Hypernatremia

The management of sodium disorders should focus on identifying the underlying cause, assessing volume status, and correcting sodium levels at appropriate rates to prevent complications such as osmotic demyelination syndrome in hyponatremia and cerebral edema in hypernatremia. 1

Hyponatremia Management

Classification and Assessment

  • Classify hyponatremia based on serum sodium levels:

    • Mild: 126-135 mEq/L
    • Moderate: 120-125 mEq/L
    • Severe: <120 mEq/L 1
  • Assess volume status to guide treatment approach:

Volume Status Clinical Signs Urine Sodium Likely Causes
Hypovolemic Orthostatic hypotension, dry mucous membranes, tachycardia <20 mEq/L GI losses, diuretics, CSW, adrenal insufficiency
Euvolemic No edema, normal vital signs >20-40 mEq/L SIADH, hypothyroidism, adrenal insufficiency
Hypervolemic Edema, ascites, elevated JVP <20 mEq/L Heart failure, cirrhosis, renal failure

Treatment Based on Volume Status

Hypovolemic Hyponatremia

  • Aggressively resuscitate with isotonic (0.9%) saline 1, 2
  • Avoid hypotonic fluids as they can worsen hyponatremia 1

Euvolemic Hyponatremia

  • Restrict free water intake 2, 3
  • For SIADH:
    • Consider fludrocortisone (0.1-0.4 mg daily) 1
    • Consider tolvaptan (vasopressin receptor antagonist) for short-term treatment (≤30 days) with a starting dose of 15 mg once daily 1, 4
    • Monitor for overly rapid correction and hypernatremia with tolvaptan use 4

Hypervolemic Hyponatremia

  • Address underlying cause (heart failure, cirrhosis, renal failure) 1, 2
  • Restrict free water 2
  • Consider vaptans for heart failure or cirrhosis 1
  • For cirrhotic patients, consider albumin infusion, especially with hypoalbuminemia 1

Severe Symptomatic Hyponatremia (Emergency)

  • For severe symptoms (altered mental status, seizures, coma):
    • Administer hypertonic (3%) saline 3
    • Target correction rate: 4-6 mEq/L in first 24 hours, not exceeding 8-10 mEq/L in 24 hours 1, 3
    • Monitor sodium levels every 2 hours initially, then every 4 hours during treatment 1

Hypernatremia Management

Assessment

  • Identify cause: insufficient water intake, excessive water loss, or iatrogenic sodium administration 2, 5
  • Evaluate volume status and severity of dehydration 6

Treatment Approach

  • Address underlying cause 2, 5
  • Replenish free water deficit 5
  • Prevent further losses 5

Rate of Correction

  • For acute hypernatremia (<48 hours): Can correct more rapidly but with careful monitoring
  • For chronic hypernatremia (>48 hours): Correct slowly over 48-72 hours to avoid cerebral edema 6
  • Monitor electrolytes, weight, and intake/output regularly 6

Important Precautions

  • Avoid overly rapid correction of hyponatremia to prevent osmotic demyelination syndrome, which can cause parkinsonism, quadriparesis, or death 1, 3
  • Avoid premixed insulin formulations in hospitalized patients with diabetes and sodium disorders due to high rates of hypoglycemia 1
  • Monitor patients on tolvaptan for hypernatremia, which occurred in 1.7% of treated patients vs. 0.8% on placebo 4
  • Be aware of drug interactions with tolvaptan, particularly strong CYP3A inhibitors which are contraindicated 4
  • Consider special populations:
    • Preterm infants are at higher risk of hyponatremia due to immature renal tubular function 1
    • Cirrhotic patients with hyponatremia have poorer prognosis and higher risk of complications 1
    • Patients with subarachnoid hemorrhage should have even mild hyponatremia (131-135 mmol/L) treated due to vasospasm risk 1

By following these management strategies based on volume status and severity, while carefully monitoring correction rates, clinicians can effectively treat sodium disorders while minimizing the risk of serious complications.

References

Guideline

Cerebral Salt Wasting Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Electrolytes: Sodium Disorders.

FP essentials, 2017

Research

Hypernatremia--problems in management.

Pediatric clinics of North America, 1976

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.